Final TIMELY Consortium Meeting Marks the Conclusion of the Project

On February 13, 2025, the 9th and final TIMELY Consortium Meeting took place in Berlin, bringing together project partners for an important discussion on the outcomes and future implications of TIMELY.

The meeting focused on Health Technology Assessment (HTA) and the evaluation of the Randomized Controlled Trial (RCT), providing key insights into the effectiveness and impact of TIMELY’s telemedicine approach. In addition, organizational aspects such as pending deliverables, final reporting, and long-term perspectives beyond the project’s official conclusion were addressed.

Participants from various TIMELY partner institutions contributed to the discussions, including representatives from BIOTRONIK, Tilburg University, Technische Universität Dresden, SEMDATEX, SERGAS, Universität Witten/Herdecke, Klinik Königsfeld, University of Milan, Medical University of Graz, Capemed, IDIVAL, University of Amsterdam, FORTH, and Universitätsklinikum Mannheim.

As TIMELY comes to an end, this final meeting served as an opportunity to reflect on the project’s achievements and explore ways to sustain its impact in the field of telemedicine and digital healthcare.

Stay tuned for further updates on the results and future applications of TIMELY!

Previous
Previous

TIMELY Final Dissemination Event: A Look Back at Key Insights and Outcomes

Next
Next

Patient Event in Tilburg Spotlights Innovations in Heart Health